For the quarter ending 2026-03-31, LIFE had $16,895K increase in cash & cash equivalents over the period. $30,856K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net income (loss) | -166,391 | 71,151 |
| Deferred taxes | 3,174 | 4,622 |
| Depreciation and amortization | 1,347 | 5,359 |
| Non-cash interest expense | 661 | 3,170 |
| Amortization of discounts and premium, investments | 182 | 1,211 |
| Stock-based compensation expense | 192,724 | 10,596 |
| Operating lease right-of-use asset amortization | 256 | 903 |
| Unrealized foreign currency translation | 112 | 303 |
| Prepaid and other assets | -12,389 | 21,350 |
| Accounts payable | 9,952 | 30,631 |
| Accounts receivable | 16,839 | 11,195 |
| Commissions receivable | -2,404 | 13,707 |
| Long-term commissions receivable | 40,802 | 51,123 |
| Accrued expenses | 14,746 | 18,920 |
| Other current liabilities | 17,882 | -8,738 |
| Other long-term liabilities | - | -1,500 |
| Net cash provided by (used in) operating activities | 31,209 | 36,225 |
| Purchase of property and equipment | 353 | 1,491 |
| Purchase of domain name | - | 500 |
| Purchase of investments | 77,187 | 66,709 |
| Proceeds from maturity of investments | 27,015 | 99,870 |
| Sales of investments | - | 4,983 |
| Investment in software development costs | 1,573 | 4,286 |
| Net cash provided by (used in) investing activities | -52,098 | 31,867 |
| Proceeds from issuance of class a common stock in initial public offering, net of underwriting discounts and commissions | 91,580 | - |
| Proceeds from liabilities related to sale of commissions receivable | 0 | 5,000 |
| Taxes paid related to net share settlement of restricted stock units | -49,085 | - |
| Repayment of liabilities related to sale of commissions receivable | 3,573 | 11,952 |
| Proceeds from exercise of stock options and warrants | 666 | 1,058 |
| Payment of deferred offering costs | 1,804 | 6,155 |
| Net cash provided by (used in) financing activities | 37,784 | -12,049 |
| Net increase in cash and cash equivalents | 16,895 | 56,043 |
| Effect of exchange rates on cash | -77 | -27 |
| Cash and cash equivalents, beginning of period | 91,091 | 35,075 |
| Cash and cash equivalents, end of period | 107,909 | 91,091 |
Ethos Technologies Inc. (LIFE)
Ethos Technologies Inc. (LIFE)